Natus Medical Interest Expense Trend

Natus Medical Incorporated -- USA Stock  

USD 30.55  0.40  1.29%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Interest Expense of Natus Medical Incorporated with missing and latest data points interpolated. Amount of the cost of borrowed funds accounted for as interest expense.
Interest Expense  10 Years Trend  
Decreasing
Slightly volatile
 Interest Expense 
      Timeline 

Natus Medical Interest Expense Over Time

2016-12-31  15,000 
2017-12-31  15,000 
2018-12-31  17,647 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  17,050
Geometric Mean  16,347
Coefficient Of Variation  38.92
Mean Deviation  3,469
Median  15,000
Standard Deviation  6,636
Sample Variance  44,032,207
Range  24,000
R Value (0.41)
Mean Square Error  39,836,268
R Squared  0.17
Significance  0.16
Slope (703.94)

Currently Trending

V   
 NYQ 
Sold over 20 shares of
2 days ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
2 days ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
2 days ago ago
Traded for 10.61